IP Verse

Procoagulant Peptides And Their Derivatives And Uses Therefor - EP2726115

The patent EP2726115 was granted to Ethicon on Sep 13, 2017. The application was originally filed on Jun 14, 2012 under application number EP12732896A. The patent is currently recorded with a legal status of "Revoked".

EP2726115

ETHICON
Application Number
EP12732896A
Filing Date
Jun 14, 2012
Status
Revoked
Nov 28, 2023
Publication Date
Sep 13, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BAXTERJun 13, 2018SONN PATENTANWALTEADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5190920
DESCRIPTIONUS5399667
DESCRIPTIONUS6045570
DESCRIPTIONUS7285580
DESCRIPTIONWO2009040034
DESCRIPTIONWO9640033
INTERNATIONAL-SEARCH-REPORTUS5399667
INTERNATIONAL-SEARCH-REPORTWO2007044026
INTERNATIONAL-SEARCH-REPORTWO2009040034
INTERNATIONAL-SEARCH-REPORTWO9640033
OPPOSITIONUS2010092467
OPPOSITIONUS5399667
OPPOSITIONWO2004028404
OPPOSITIONWO2008076407
OPPOSITIONWO2009040034
OPPOSITIONWO9808550

Non-Patent Literature (NPL) Citations (18) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- BONNEFOY ET AL., "A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor", J BIOL CHEM, (2001), vol. 276, pages 5605 - 5612
DESCRIPTION- BONNEFOY ET AL., "The evolving role of thrombospondin-1(TSP1) in hemostasis and vascular biology", CELL. MOL. LIFE SCI., (2008), vol. 65, pages 713 - 727, XP019583924
DESCRIPTION- CHUNG ET AL., "Thrombospondin-1 acts via IAP/CD47 to synergize with collagen in alpha2betal-mediated platelet activation", BLOOD, (19990715), vol. 94, no. 2, pages 642 - 8, XP002691637
DESCRIPTION- CHUNG ET AL., "Thrombspondin Acts via Integrin-associated Protein to Activate the Platelet Integrin aIIbb3", J BIOL CHEM, (19970606), vol. 272, no. 23, pages 14740 - 14746
DESCRIPTION- FUJIMOTO ET AL., "Thrombospondin-bound integrin-associated protein (CD47) physically and functionally modifies integrin alphallbbeta3 by its extracellular domain", J BIOL CHEM, (2003), vol. 278, pages 26655 - 26665
DESCRIPTION- TRUMEL ET AL., "Platelet aggregation induced by the C-terminal peptide of thrombospondin- requires the docking protein LAT but is largely independent of alphallb/beta3", JOURNAL OF THROMBOSIS AND HAEMOSTASIS, (200302), vol. 1, no. 2, pages 320 - 9
DESCRIPTION- TUSZYNSKI ET AL., "Thrombospondin promotes platelet aggregation", BLOOD, (1988), vol. 72, pages 109 - 115
DESCRIPTION- VOIT ET AL., "The C-terminal peptide of thrombospondin- stimulates distinct signaling pathways but induces an activation-independent agglutination of platelets and other cells", FEBS LETTERS, (2003), vol. 544, doi:doi:10.1016/S0014-5793(03)00472-1, pages 240 - 245, XP004427900
DESCRIPTION- DORAHY ET AL., "Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor", J. BIOL CHEM, (1997), vol. 272, doi:doi:10.1074/jbc.272.2.1323, pages 1323 - 1330, XP002691639
DESCRIPTION- TULASNE ET AL., "C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor chain-associated signaling pathway and by agglutination", BLOOD, (2001), vol. 98, doi:doi:10.1182/blood.V98.12.3346, pages 3346 - 3352, XP055309984
INTERNATIONAL-SEARCH-REPORT- J. CHUNG ET AL., "Thrombospondin-1 Acts Via IAP/CD47 to Synergize With Collagen in alpha2beta1-Mediated Platelet Activation", BLOOD, (19990715), vol. 94, no. 2, pages 642 - 648, XP002691637 [X] 1-4,22,23,25 * the whole document * [Y] 1-27
INTERNATIONAL-SEARCH-REPORT[ ] - TRUMEL C ET AL, "Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 requires the docking protein LAT but is largely independent of alphaIIb/beta3.", JOURNAL OF THROMBOSIS AND HAEMOSTASIS : JTH FEB 2003, (200302), vol. 1, no. 2, ISSN 1538-7933, pages 320 - 329
INTERNATIONAL-SEARCH-REPORT- TRUMEL C ET AL, "Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 requires the docking protein LAT but is largely independent of alphaIIb/beta3.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200302), Database accession no. NLM12871507, XP002691638 [Y] 1-27 * abstract *
INTERNATIONAL-SEARCH-REPORT- D.J. DORAHY ET AL., "Stimulation of Platelet Activation and Aggregation by a Carboxyl-terminal Peptide from Thrombospondin Binding to the Integrin-associated Protein Receptor", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (19970110), vol. 272, no. 2, XP002691639 [YD] 1-27 * the whole document *
OPPOSITION- CHUNG et al., "Thrombospondin-1 Acts Via IAP/CD47 to Synergize With Collagen in .alpha.2.beta.1-Mediated Platelet Activation", Blood, (19990000), vol. 94, pages 642 - 648, XP002691637
OPPOSITION- TRUMEL et al., "Platelet aggregation induced by the C‐terminal peptide of thrombospondin‐1 requires the docking protein LAT but is largely independent of αIIb/β3", J. Thromb. Hemost., (20030000), vol. 1, pages 320 - 329, XP055609057
OPPOSITION- DORAHNY et al., "Stimulation of Platelet Activation and Aggregation by a Carboxyl-terminal Peptide from Thrombospondin Binding to the Integrin-associated Protein Receptor", JBC, (19970000), vol. 272, pages 1323 - 1330, XP002691639
OPPOSITION- TULASNE et al., "C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor gamma -chain-associated signaling pathway and by agglutination", Blood, (20010000), vol. 98, no. 12, pages 3346 - 3352, XP055309984

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents